Views of European Drug Development Stakeholders on Treatment Optimization and Its Potential for Use in Decision-Making

BACKGROUND: The current drug development paradigm has been criticized for being too drug-centered and for not adequately focusing on the patients who will eventually be administered the therapeutic interventions it generates. The drug-driven nature of the present framework has led to the emergence o...

Descripción completa

Detalles Bibliográficos
Autores principales: Saesen, Robbe, Lejeune, Stéphane, Quaglio, Gianluca, Lacombe, Denis, Huys, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7015135/
https://www.ncbi.nlm.nih.gov/pubmed/32116718
http://dx.doi.org/10.3389/fphar.2020.00043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7015135/
https://www.ncbi.nlm.nih.gov/pubmed/32116718
http://dx.doi.org/10.3389/fphar.2020.00043

Ejemplares similares